Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 12, 2025 QUARTERLY REPORT
4 Aug 7, 2025
SCHEDULE 13D/A Jul 25, 2025
8-K Jul 18, 2025 CURRENT REPORT
424B4 Jul 17, 2025 PROSPECTUS
EFFECT Jul 16, 2025
CORRESP Jul 15, 2025
S-1/A Jul 14, 2025 AMENDMENT NO. 1 TO FORM S-1
S-1 Jul 14, 2025 REGISTRATION STATEMENT
8-K Jun 27, 2025 CURRENT REPORT
8-K Jun 17, 2025 CURRENT REPORT
10-Q May 14, 2025 QUARTERLY REPORT
8-K May 14, 2025 CURRENT REPORT
UPLOAD May 1, 2025
DRS Apr 28, 2025
8-K Apr 25, 2025 FORM 8-K
8-K Apr 3, 2025 CURRENT REPORT
DEFA14C Feb 24, 2025 DEFINITIVE ADDITIONAL MATERIALS
DEF 14C Feb 24, 2025 DEFINITIVE INFORMATION STATEMENT
8-K Feb 14, 2025 CURRENT REPORT
10-Q Feb 14, 2025 QUARTERLY REPORT
PRE 14C Feb 12, 2025 PRELIMINARY INFORMATION STATEMENT
8-K Feb 6, 2025 CURRENT REPORT
10-K/A Jan 27, 2025 AMENDMENT NO. 1 TO FORM 10-K
8-K Jan 7, 2025 CURRENT REPORT
← Newer Page 5 of 11 · 268 filings Older →